LiFSI expansion for Nippon Shokubai
Submitted by:
Andrew Warmington
Japan’s Nippon Shokubai will more than quintuple capacity for its Ionel brand of lithium bis(fluorosulfonyl)imide
Changes at the top for Dow, Evonik
Submitted by:
Andrew Warmington
Dow has named Karen S. Carter, currently COO, as its new CEO with effect
Neuland to open peptide facility this summer
Submitted by:
Andrew Warmington
India’s Neuland Laboratories has announced that it will open the first of four planned modules at
Indorama buys Venator site
Submitted by:
Andrew Warmington
Through its local subsidiary, Indorama Advanced Oxides (Spain), Indorama has acquired Venator Materials’ TiO2 manufacturing
Lonza becomes pure-play CDMO
Submitted by:
Andrew Warmington
Lonza has entered into a definitive agreement to divest its Capsules & Health Ingredients (CHI)
Celtic secures more funding
Submitted by:
Andrew Warmington
Celtic Renewables, a spin-out from Edinburgh Napier University, has secured £16.23 million in public and
WeylChem Elgin site to cease production
Submitted by:
Andrew Warmington
WeylChem is to discontinue production at its site in Elgin, South Carolina. The company said
Wacker to cut jobs
Submitted by:
Andrew Warmington
Wacker Chemie has launched a project called PACE “to make significant cost savings in its
Feature article - Nitrosamine mitigation: Delivering a dose of clarity in three key questions
Submitted by:
Andrew Warmington
Amit Chivate, senior market manager, Greater Asia & China, at Roquette Health & Pharma Solutions
Recipharm in regulatory partnership
Submitted by:
Andrew Warmington
CDMO Recipharm has formed a strategic collaboration that will combine its integrated development and manufacturing